Novozymes accelerates growth in Q3 and is on track to deliver on full-year expectations
26 oct. 2023 02h01 HE
|
Novozymes A/S
After the first nine months of the 2023 financial year, Novozymes sees increasing demand for sustainable biosolutions and delivers 5% organic sales growth. The full-year organic sales growth outlook...
Novozymes launches new biosolution to redefine the plant-based meat experience by enhancing texture and encouraging more consumers to choose plant-based alternatives
28 sept. 2023 02h48 HE
|
Novozymes A/S
Novozymes is excited to offer Vertera® ProBite as a game-changing solution to the plant-based meat industry, opening up new possibilities to create today's and tomorrow's plant-based meat products...
Novozymes’ and Chr. Hansen’s shareholders approve combination to create a leading global biosolutions partner
30 mars 2023 12h00 HE
|
Novozymes A/S
The proposed combination of Novozymes and Chr. Hansen has now been approved by each company’s respective shareholders, and with strong support from the shareholders the two biosolutions companies...
As one of the first companies in the world, Novozymes has had its net-zero target validated by the Science Based Targets initiative
10 nov. 2022 05h14 HE
|
Novozymes A/S
Novozymes has renewed its climate targets and by 2030 will reduce its absolute CO2 emissions across its operation by 75% and reduce its absolute CO2 emissions from its supply chain by 35%. By 2050,...
Novozymes and LinusBio announce collaboration to accelerate scientific discovery in Biohealth
10 nov. 2022 03h02 HE
|
Novozymes A/S
COPENHAGEN, Denmark – November 10, 2022. Novozymes, the world leader in biological solutions, and LinusBio (Linus Biotechnology Inc.), a leader in precision exposome sequencing, today announced the...
Novozymes confirms upgraded guidance by strong start to Q4
03 nov. 2022 03h00 HE
|
Novozymes A/S
Novozymes delivered 9% organic sales growth in the first nine months of 2022 and 6% organic sales growth in the third quarter. As announced on October 7, the full-year organic sales growth outlook was...
Novozymes Named EPA Safer Choice Partner of the Year for Second Consecutive Year
01 nov. 2022 12h00 HE
|
Novozymes A/S
Novozymes Named EPA Safer Choice Partner of the Year for Second Consecutive Year World’s Leading Biotech Powerhouse Recognized for Providing and Advocating for Ingredients that Create Safer...
Novozymes delivers strong 2022 Q1 results and raises full-year financial guidance
26 avr. 2022 09h14 HE
|
Novozymes A/S
Novozymes delivered solid earnings and double-digit organic sales growth in the first quarter of 2022. Despite negative effects of the tragic war in Ukraine the company increases its full-year organic...
Novozymes delivers strong 2021 full-year results and expects continued, solid progress in 2022
01 févr. 2022 02h01 HE
|
Novozymes A/S
Novozymes is executing on its strategic framework by delivering 6% organic sales growth for 2021 and presenting a solid organic growth outlook of 3-7% for 2022. The company is also on track to meet...
Novozymes and Saipem enter collaboration agreement to create a more sustainable CO2 capture
13 déc. 2021 02h02 HE
|
Novozymes A/S
The partnership will develop new biotech solutions aimed at carbon capture through enzymes. COPENHAGEN, DENMARK – December 13, 2021 – Novozymes, the world leader in biological solutions, and...